Injective has announced the launch of its native Ethereum Virtual Machine (EVM) testnet, providing developers with the opportunity to create compatible decentralized applications on its blockchain.
Launch of EVM Testnet
On July 2, Injective announced the launch of its EVM testnet, which will allow developers to run Ethereum-compatible decentralized applications directly on its Layer 1 blockchain. This move follows the company’s January announcement about integrating a native EVM to expand smart contract capabilities and enhance interoperability with the Ethereum ecosystem.
Integration with Injective Architecture
The native EVM is fully integrated into Injective’s core architecture, enabling the execution of Ethereum smart contracts without relying on external interoperability layers. "Unlike rollups or external interoperability solutions, this is a truly native implementation of EVM where the entire system operates solely on Injective’s infrastructure," the team stated.
Advantages of the New EVM
This new EVM will also allow developers access to Injective’s on-chain order book and advanced exchange features, enhancing decentralized trading options. The integration utilizes the latest Geth client software to ensure compatibility with Ethereum tools and standards, supporting high transaction throughput. Performance tests indicate that the EVM can process around 800 lightweight transactions per second and 320 heavy transactions per second while fully utilizing the block gas limit of 50 million.
The launch of Injective’s EVM testnet opens new horizons for developers, allowing them to create more complex and diverse decentralized applications using its blockchain.